Giving

A New Chapter for Stanford Biodesign

In our first two decades, we launched a new generation of health technology innovators while sharing our needs-based innovation process around the globe. These amazing Stanford Biodesigners, some of the world’s most talented minds, have invented hundreds of new health technologies, launched dozens of companies, raised hundreds of millions of dollars, and helped millions of people. They’ve also taught thousands of others our unique biodesign innovation process.

Stanford Biodesign achieved these results with the support of our industry, foundation, and individual donors. We rely almost completely on philanthropic gifts to run our yearly programs.

As we look to the next few decades, there is so much more to do. Our potential to expand our impact has never been greater. We’re deeply thankful to Linda and Mike Mussallem for seeing this potential and making a transformative gift to help sustain Stanford Biodesign into the future. It is their hope that others will be inspired to follow suit and support this important program.

Our purpose at the Stanford Mussallem Center for Biodesign remains:

Advancing health outcomes and equity through innovation education, translation, and policy.

While continuing to train aspiring innovators and empowering them to deliver solutions to the world’s biggest health challenges, we are expanding our efforts across the rapidly changing health ecosystem through three strategic initiatives:

• Impact Health Policy. Without effective health policies, the best innovations may never achieve their desired impact. Through a rigorous research agenda and policy-oriented educational programs, we are proactively informing policy makers and affecting the policy debate so that more patients get timely access to life-changing technology innovations.
• Leverage All Lifesciences. New technological advances now make it possible to apply our need-driven approach beyond medical devices, device-based diagnostics, and digital health to segments of the biotechnology and pharmaceutical fields. We are adapting our process to support effective and efficient biopharma innovation that makes a whole new solution set available to our trainees and the patients they serve.  
• Enable Better Health for All. Not all communities have benefited equally from technological innovation in the healthcare sector. However, technology – done right – has the potential to equalize health access and outcomes. Toward this end, we are embedding health equity considerations at every step in our teaching, and forging targeted partnerships with a mission to improve health and healthcare for traditionally underserved populations in the US and internationally.

Your involvement will help us achieve these new initiatives while continuing to teach and share the biodesign innovation process for generations to come. Together we can ensure a future where the greatest advances in health technology are realized, leading to a healthier world for all.

Join us.

Josh Makower
Director, Stanford Biodesign